100% Same
Salt CompositionEffectivenessStrength
with Substitute Medicine
Salt Composition in bothYou Searched
Our Recommendation
Voxa 50mg Tablet 10s
3,440+ trust this
WHO GMP Certified
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Delivery by
Used In
Depression / Obsessive-compulsive disorder
Customers also bought
More About Revilife 50mg Tablet 10s
Benefits
In Depression REVILIFE 50 MG TABLET works by increasing the level of a chemical called serotonin in the brain. This improves your mood, relieves anxiety, tension, and helps you sleep better. It has fewer side effects than older antidepressants. It usually takes 4-6 weeks for this medicine to work so you need to keep taking it even if you feel it is not working. Do not stop taking it, even if you feel better unless your doctor advises you to. In Obsessive-compulsive disorder REVILIFE 50 MG TABLET helps relieve symptoms of many anxiety disorders such as obsessive-compulsive disorder by increasing the level of a chemical called serotonin in your brain. It has fewer side effects than older antidepressants and is normally taken once a day. It helps you feel calm with a better ability to deal with problems. Exercise and a healthy diet can also improve your mood. Keep taking the medicine until your doctor advises you to stop.
Side Effects
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
How to use
Follow your doctor's guidance regarding the dose and duration of this medication. Ingest it without breaking or crushing. Do not chew, crush or break it. REVILIFE 50 MG TABLET can be taken it with or without food, although it's advisable to take it consistently at the same time.
How it works
REVILIFE 50 MG TABLET is a selective serotonin reuptake inhibitor (SSRI) antidepressant. It works by increasing the levels of serotonin, a chemical messenger in the brain. This improves mood and physical symptoms of depression and also relieves symptoms of obsessive-compulsive disorders.
Unsafe: Avoid consuming alcohol with REVILIFE 50 MG TABLET as it is deemed unsafe.
Seek medical advice from your doctor: REVILIFE 50 MG TABLET may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Doctor consultation is advised.
Seek medical advice from your doctor: REVILIFE 50 MG TABLET is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
SAFE - REVILIFE 50 MG TABLET does not usually affect your ability to drive.
Safe when prescribed by an expert: REVILIFE 50 MG TABLET is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of REVILIFE 50 MG TABLET may not be needed in these patients. Doctor consultation is advised.
Caution Advised: REVILIFE 50 MG TABLET should be used with caution in patients with liver disease. Dose adjustment of REVILIFE 50 MG TABLET may be needed. Doctor consultation is advised.
What if I forget to take it?
If a dose of REVILIFE 50 MG TABLET is missed, take it promptly. However, if your next dose is approaching, skip the missed dose and resume your regular schedule. Avoid doubling the dose.
Manufacturer Address
16th Floor, Godrej BKC, Plot ‚ C, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai ‚ 400 051, India
References
Stahl SM, editor. Fluvoxamine. In: Stahl's Essential Pschopharmacology: Prescriber's Guide. 5th ed. New York, New York: Cambridge University Press; 2014. pp. 269-74
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 578-81
Fluvoxamine maleate. Jazz Pharmaceuticals; 1994 (25 Mar. 2019)
Chaves RG, Lamounier JA. Breastfeeding and maternal medications. J Pediatr (Rio J). 2004;80(5 Suppl):S189-S198 (20 Mar. 2019)
Central Drugs Standard Control Organisation (CDSCO) (25 Mar. 2019)
Fluvoxamine Tablets (03 Jul. 2023)
Fluvoxamine maleate (03 Jul. 2023)
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
